Encompass Health Corp (EHC) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Encompass Health’s revenue went from $3.6B in fiscal 2016 to $5.9B in fiscal 2025, growth of about 5.6% a year.
Net income in fiscal 2025 was $566M, a net margin of 9.5%; the highest of the period.
Over the twelve months to September 30, 2026, revenue was $6.3B and net income $644M.
Free cash flow was $439M in fiscal 2025 and positive in 10 of the 10 years shown.
The diluted share count rose 3% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.3B | $5.9B | $5.4B | $4.8B | $4.3B | $4.0B | $3.6B | $4.6B | $4.3B | $3.9B | $3.6B |
| Gross profit | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | $1.2B | $1.1B | $864M | $732M | $540M | $560M | $564M | $612M | $555M | $578M | $588M |
| Net income | $644M | $566M | $456M | $352M | $271M | $412M | $284M | $359M | $292M | $271M | $248M |
| EPS (diluted) | $6.40 | $5.54 | $4.46 | $3.47 | $2.70 | $4.11 | $2.85 | $3.61 | $2.93 | $2.84 | $2.59 |
| R&D | — | — | — | — | — | — | — | — | — | — | — |
| Revenue growth | — | +10.5% | +11.9% | +10.4% | +8.3% | +12.6% | −22.6% | +7.7% | +9.3% | +7.4% | +15.2% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.3B | $1.2B | $1.0B | $851M | $706M | $716M | $705M | $635M | $762M | $658M | $640M |
| Capital spending | -$846M | -$736M | -$642M | -$583M | -$565M | -$525M | -$393M | -$372M | -$254M | -$226M | -$178M |
| Free cash flow | $457M | $439M | $360M | $268M | $141M | $191M | $312M | $263M | $508M | $432M | $462M |
| Dividends paid | $77M | $71M | $63M | $60M | $99M | $112M | $112M | $109M | $101M | $92M | $84M |
| Buybacks | $280M | $158M | $31M | $0 | $0 | $0 | $6M | $46M | $0 | $38M | $66M |
| Stock-based pay | $59M | $56M | $48M | $51M | $29M | $29M | $26M | $114M | $86M | $48M | $27M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $72M | $85M | $69M | $22M | $49M | $186M | $60M | $69M | $54M | $40M |
| Debt | — | $2.7B | $2.7B | $2.9B | $3.0B | $3.5B | $3.5B | $3.3B | $2.5B | $2.6B | $3.0B |
| Equity | — | $2.4B | $2.1B | $1.6B | $1.3B | $1.9B | $1.6B | $1.4B | $1.3B | $1.2B | $736M |
| Total assets | — | $7.1B | $6.5B | $6.1B | $5.6B | $6.9B | $6.4B | $6.1B | $5.2B | $4.9B | $4.7B |
| Shares (diluted) | 100M | 102M | 102M | 101M | 100M | 100M | 100M | 99M | 100M | 99M | 100M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | — | — | — | — | — |
| Operating margin | 18.8% | 17.7% | 16.1% | 15.2% | 12.4% | 13.9% | 15.8% | 13.3% | 13.0% | 14.8% | 16.2% |
| Net margin | 10.2% | 9.5% | 8.5% | 7.3% | 6.2% | 10.3% | 8.0% | 7.8% | 6.8% | 6.9% | 6.8% |
| FCF margin | 7.2% | 7.4% | 6.7% | 5.6% | 3.2% | 4.8% | 8.8% | 5.7% | 11.9% | 11.1% | 12.7% |
| ROIC | — | 16.3% | 14.5% | 12.5% | 9.8% | 8.2% | 8.7% | 10.3% | 11.1% | 10.9% | 10.3% |
| ROE | — | 23.2% | 22.1% | 21.4% | 20.7% | 21.6% | 17.9% | 26.5% | 22.9% | 23.5% | 33.7% |
Frequently asked questions
What is Encompass Health’s annual revenue?
$5.9B in fiscal 2025 and $6.3B over the twelve months to September 30, 2026.
How much profit does Encompass Health make?
Net income was $566M in fiscal 2025 (net margin 9.5%).
Is Encompass Health’s revenue growing?
Yes: revenue rose 10.5% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.